Denosumab Versus Zoledronic Acid in Cases of Surgically Unsalvageable Giant Cell Tumor of Bone: A Randomized Clinical Trial

ConclusionsDenosumab is a safe but costly alternative to zoledronic acid for treatment of surgically unsalvageable giant cell tumor of bone.Graphical Abstract
Source: Journal of Bone Oncology - Category: Cancer & Oncology Source Type: research